The "Squawk on the Street" news team reports on the top business headlines of the day; including the first anniversary of CNBC's "Post Nine" on the floor of the NYSE; Apple's annual shareholders meeting; and more.
Mark Okada, Highland Capital, explains how a reduction in the Fed's bond-buying program could produce a flight to junk bonds among investors.
Check out which companies are making headlines before the bell Wednesday:
Dino Kos, CLS Bank International, discusses the Fed's stimulus program, and its impact on the markets, with Bob Doll, Nuveen Investment Management.
The recent market sell-off has brought materials stocks lower, and now they're gaining some attention.
Patrick McKeever, MKM Partners analyst, breaks down the big box retailer's fourth quarter numbers of $1.65 ex-items EPS vs. $1.48 estimates, on revenues of $22.73 billion.
Stuart Hoffman, PNC Financial Services; Bob Doll, Nuveen Asset Management; and Alec Young, S&P Capital IQ, talk about the economic headwinds facing the market, and weigh in on worries about the looming sequester.
Michael Tyler, Eastern Bank, discusses how current Fed policy is impacting the economy and what to expect from sequestration. Also, Alan Knuckman provides a look at how to play the markets now.
CNBC's Ross Westgate reports yields on Italian bonds reached their highest levels since October 2012 at an auction of five and ten-year debt.
CNBC's Ross Westgate tells you what the markets will be watching as we approach the start of trading in the U.S. (1:18)
David Rubenstein, co founder and co CEO, The Carlyle Group, says that while he suspects the sequester will go ahead in the U.S., it will not affect his approach to long-term investments in the country.
Dan Scott, head of event driven research at Credit Suisse, tells CNBC that they went tactically neutral before the Italian election but they remain bullish on equities long-term.
Ana Armstrong, CEO of Armstrong Investment Managers, tells CNBC that a near-time consolidation in equity markets is likely due to the Italian election.
Kelvin Tay, Regional CIO for Southern APAC at UBS Wealth Management, warns that equity markets are set for a choppy ride in the coming months.
Jim Cramer has an idea for how Apple could spend some of its billions in cash and he thinks it's better than what investor David Einhorn is pushing (4:13)
Volatility calmed down Tuesday but brace yourself: Pros say bigger gyrations could be the norm for the next few weeks as investors watch what's going on in Washington and Europe.
The "Mad Money" host comments on viewers' favorite stocks!
Biotech Immunogen showed signs of life today after getting FDA approval of a new breast cancer treatment. Cramer talks to CEO Daniel Junius about the progress of the drug and when patients will see it in doctor's offices, as well as what it means to the company.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
There are many issues for investors to worry about, but Cramer thinks there is still opportunity out there.